Importantly, FGL2 is over-expressed in colorectal carcinoma (CRC) and clear cell renal cell carcinoma (ccRCC) tumors compared to non-tumor tissues [25, 37], and the expression levels are associated with cell proliferation and invasion in vitro and with CRC progression and metastasis in vivo [37]. Here, FGL2 is linked to clear cell renal carcinoma.